We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+8.41%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.54B
AUM Growth
-$44M
Cap. Flow
-$103M
Cap. Flow %
-6.66%
Top 10 Hldgs %
10.05%
Holding
662
New
91
Increased
91
Reduced
211
Closed
114

Top Buys

Rank Stock Value
1
FMC icon
FMC
FMC
+$11.1M
2
LVS icon
Las Vegas Sands
LVS
+$9.43M
3
EXPE icon
Expedia Group
EXPE
+$8.63M
4
TXN icon
Texas Instruments
TXN
+$8.41M
5
TRU icon
TransUnion
TRU
+$8.01M

Top Sells

Rank Stock Value
1
STX icon
Seagate
STX
+$12.9M
2
WDC icon
Western Digital
WDC
+$11.6M
3
VSAT icon
Viasat
VSAT
+$10.2M
4
CPNG icon
Coupang
CPNG
+$9.66M
5
CLS icon
Celestica
CLS
+$5.93M

Sector Composition

Rank Sector Weight
1 Technology 17.6%
2 Consumer Discretionary 16.55%
3 Healthcare 14.73%
4 Industrials 14.64%
5 Financials 11.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLI icon
126
Houlihan Lokey
HLI
$10.2B
$4.32M 0.28%
24,781
-7,834
-24% -$1.44M
IONS icon
127
Ionis Pharmaceuticals
IONS
$9.12B
$4.3M 0.28%
54,365
ESE icon
128
ESCO Technologies
ESE
$8.2B
$4.27M 0.28%
21,874
PAY icon
129
Paymentus
PAY
$4.28B
$4.27M 0.28%
135,061
+8,400
+7% +$274K
PGY icon
130
Pagaya Technologies
PGY
$1.37B
$4.24M 0.28%
203,044
AUPH icon
131
Aurinia Pharmaceuticals
AUPH
$1.92B
$4.23M 0.27%
265,491
NSP icon
132
Insperity
NSP
$1.98B
$4.21M 0.27%
108,662
+91,960
+551% +$3.67M
KNSA icon
133
Kiniksa Pharmaceuticals
KNSA
$6.18B
$4.19M 0.27%
101,622
SNOW icon
134
Snowflake
SNOW
$93.6B
$4.16M 0.27%
18,948
-3,000
-14% -$732K
UWMC icon
135
UWM Holdings
UWMC
$628M
$4.15M 0.27%
947,675
+505,257
+114% +$2.72M
NBIX icon
136
Neurocrine Biosciences
NBIX
$18.3B
$4.08M 0.26%
28,781
-12,823
-31% -$1.86M
RARE icon
137
Ultragenyx Pharmaceutical
RARE
$2.55B
$4.07M 0.26%
176,813
+20,120
+13% +$662K
CHWY icon
138
Chewy
CHWY
$9.36B
$3.98M 0.26%
120,400
+27,979
+30% +$971K
APPN icon
139
Appian
APPN
$2B
$3.96M 0.26%
111,801
-18,619
-14% -$663K
G icon
140
Genpact
G
$5.82B
$3.95M 0.26%
84,523
+30,384
+56% +$1.31M
CTAS icon
141
Cintas
CTAS
$85.8B
$3.95M 0.26%
+21,001
New +$3.96M
COR icon
142
Cencora
COR
$62.2B
$3.95M 0.26%
11,690
-4,600
-28% -$1.57M
DKS icon
143
Dick's Sporting Goods
DKS
$18.9B
$3.92M 0.25%
19,812
-8,700
-31% -$1.9M
W icon
144
Wayfair
W
$12.3B
$3.88M 0.25%
38,689
ALGT icon
145
Allegiant Air
ALGT
$2.75B
$3.87M 0.25%
45,369
-1,400
-3% -$100K
PTON icon
146
Peloton Interactive
PTON
$2.8B
$3.85M 0.25%
624,286
-232,250
-27% -$1.63M
SUPN icon
147
Supernus Pharmaceuticals
SUPN
$2.74B
$3.81M 0.25%
76,673
-11,600
-13% -$564K
CRL icon
148
Charles River Laboratories
CRL
$11.5B
$3.81M 0.25%
19,100
CASY icon
149
Casey's General Stores
CASY
$31.7B
$3.79M 0.25%
+6,852
New +$3.77M
MFC icon
150
Manulife Financial
MFC
$74.1B
$3.78M 0.25%
104,102
-58,079
-36% -$1.97M

Similar funds

PDT Partners's Q4 2025 Portfolio in Review

As of Q4 2025, PDT Partners held 662 positions worth $1.54B, down 2.8% from $1.59B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

PDT Partners withdrew a net $103M in Q4 2025, closing 114 positions and reducing 211 holdings. Its most notable exit was Seagate, an estimated $12.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, PDT Partners opened a new position in FMC worth $8.09M.

  • PDT Partners's largest Q4 2025 buy was FMC: 583,388 shares worth $8.09M.
  • PDT Partners added most to Las Vegas Sands in Q4 2025, an estimated $9.43M increase.
  • PDT Partners's biggest Q4 2025 reduction was Viasat, cutting an estimated $10.2M.
  • PDT Partners fully exited Seagate in Q4 2025, selling an estimated $12.9M.
  • PDT Partners's ten largest holdings make up 10% of its $1.54B portfolio in Q4 2025.
  • PDT Partners opened 91 new positions and closed 114 in Q4 2025.
  • PDT Partners's portfolio value fell 2.8% quarter-over-quarter to $1.54B.

Based on PDT Partners's 13F filing for Q4 2025, filed 17 Feb 2026.